Humulin n and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humulin n (insulin susp isophane recombinant human) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include dyspnoea among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Humulin n and Dilaudid. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Humulin n?

Humulin n has active ingredients of insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 9,878 Humulin n users. Check the latest studies of Humulin n.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.



On Aug, 07, 2026

22 people who take Humulin n and Dilaudid together, and have interactions are studied.

Humulin n and Dilaudid drug interactions.

What are the common drug interactions of Humulin N and Dilaudid, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Herpes virus infection
  3. Intestinal obstruction
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Neoplasm progression (growth of tumour)
  6. Oral candidiasis (fungal infection of mouth)
  7. Sinusitis (inflammation of sinus)
  8. Urinary tract infection
  9. Vulvovaginal candidiasis (vulvovaginal infection by fungi)
  10. Abdominal pain

male:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Headache (pain in head)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Depressed level of consciousness
  5. Diarrhoea
  6. Drug dependence
  7. Drug ineffective
  8. Drug tolerance increased
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Duodenitis (inflammation of the duodenum)

What are the common drug interactions of Humulin N and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cholecystitis (infection of gallbladder)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Confusional state
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Depressed level of consciousness
  6. Diarrhoea
  7. Drug dependence
  8. Drug ineffective
  9. Drug tolerance increased
  10. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

50-59:

  1. Blood glucose increased
  2. Anaemia (lack of blood)
  3. Asthenia (weakness)
  4. Catheter site pain
  5. Diastolic dysfunction
  6. Failure to thrive (inadequate weight gain and physical growth in children)
  7. Lumbar vertebral fracture
  8. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  9. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Fall
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Body tinea (ringworm of the body)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Dyspnoea (difficult or laboured respiration)
  8. Haemorrhage (bleeding)
  9. Herpes virus infection
  10. Intestinal obstruction

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 5 people, 22.73%
  2. Type 2 Diabetes: 4 people, 18.18%
  3. High Blood Pressure: 4 people, 18.18%
  4. Sinusitis (inflammation of sinus): 4 people, 18.18%
  5. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 3 people, 13.64%
  6. Dyslipidaemia (abnormal amount of lipids): 3 people, 13.64%
  7. Back Pain: 3 people, 13.64%
  8. Abdominal Pain: 3 people, 13.64%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.09%
  10. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Humulin n and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Humulin n and Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humulin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humulin n and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin susp isophane recombinant human and hydromorphone hydrochloride (the active ingredients of Humulin n and Dilaudid, respectively), and Humulin n and Dilaudid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: